Skip to content
Research Article Open access CC BY 4.0

Formulation and in vitro Characterization of Donepezil-loaded Chitosan Nanoparticles

Muhammad Wahab Amjad, Nawaf Mohamed Alotaibi

Journal of Pharmaceutical Research International · pp. 10–16 · Published 23 Jun 2020

10.9734/jpri/2020/v32i1030488

Abstract

Millions of people are affected globally by alzheimer’s disease and it is regarded as a dangerous progressive medical and socio-economic burden. The drug delivery to brain is hindered due to the presence of blood brain barrier. Nanoparticle mediated drug delivery is a promising approach in this regard. Chitosan is a hydrophilic polysaccharide polymer of N-acetylglycosamine and glucosamine. Owing to its biodegradability, nontoxicity and biocompatibility it is regarded as a safe excipient. The aim of the study was to fabricate donepezil-loaded sustained release chitosan nanoparticles as a simple way to deliver nano-drugs to the brain. The nanoparticles were fabricated using ionic gelation method using different concentrations of Sodium tripolyphosphate (TPP) and chitosan. The fabricated nanoparticles were assessed for particle size, zeta potential, encapsulation efficiency and in vitro drug release. The effect of sonication time on the particle size of nanoparticles was also studied. The nanoparticles exhibited mean particle size (between 135-1487 nm) and zeta potential (between +3.9-+38mV) depending on chitosan and TPP concentration used. The rise in the sonication time from 25 to 125 sec exhibited a decrease in particle size. The encapsulation efficiency was found to be in the range of 39.1-74.4%. Sustained and slow release of donepezil at a constant rate was exhibited from nanoparticles. The nanoparticles show potential to deliver donepezil to brain with enhanced encapsulation efficiency.

Chitosan donepezil nanoparticles encapsulation efficiency drug release.

Cited by 9

Nanomedicine Solutions for Alzheimer’s Disease: A Critical Review of Therapeutic Nanoparticle Strategies

Teboho E. Tutubala, Ayodeji O. Egunlusi, David Fisher · ACS Omega · 2025

Chitosan based controlled release drug delivery of mycophenolate mofetil loaded in nanocarriers system: synthesis and in-vitro evaluation

Muhammad Zaman, Asma Iqbal, Syed Farhan Haider Rizvi · Drug Development and Industrial Pharmacy · 2021

Functionalized nanoparticles based on β-chitosan and styrene copolymer derivative for donepezil delivery

Fahima M. Helaly, Ahmed A. F. Soliman, Eman AboBakr Ali · 3 Biotech · 2025

Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's

Nikita Subhash Hinge, Himanshu Kathuria, Murali Monohar Pandey · Applied Materials Today · 2022

Chitosan nanoparticle encapsulation improves the effect of donepezil on impaired memory in an amnesia mouse model

Mahmoud Heidari, Nasrinsadat Azami, Mehdi Ebadi · Discover Medicine · 2024

Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management

Baljinder Singh, Candace M. Day, Sadikalmahdi Abdella · Journal of Controlled Release · 2024

Characterization and anti-Alzheimer's effect of donepezil-loaded chitosan/polyethylene glycol nanospheres

Gita Parviz, Ece Guler, Ayse Nur Hazar-Yavuz · Journal of Drug Delivery Science and Technology · 2025

Showing 8 of 9 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

9

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.